Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes

Area of Science:

• Perinatal Medicine
• Neonatology
• Obstetrics

Background:

• Histologic chorioamnionitis is a placental inflammation associated with adverse perinatal outcomes.
• The impact of antenatal steroid administration on neonates with histologic chorioamnionitis requires further elucidation.

Purpose of the Study:

• To investigate the perinatal effects of histologic chorioamnionitis on preterm neonates.
• To evaluate the efficacy of antenatal steroids in mitigating these effects.

Main Methods:

• Retrospective study of neonates weighing ≤1750 g born between 1990-1997.
• Stratification based on histologic chorioamnionitis and antenatal steroid exposure.
• Statistical analysis using t-tests, chi-squared, Fisher exact test, and logistic regression.

Main Results:

• Histologic chorioamnionitis was associated with lower gestational age, lower birth weight, and increased major neonatal morbidities.
• Antenatal steroid exposure in cases of histologic chorioamnionitis significantly reduced respiratory distress syndrome, intraventricular hemorrhage, major brain lesions, and neonatal death.
• No increased incidence of proven neonatal sepsis was observed with antenatal steroid use in this cohort.

Conclusions:

• Histologic chorioamnionitis independently increases perinatal morbidity and neonatal mortality, primarily through its association with preterm birth.
• Antenatal steroids demonstrate significant protective effects against major morbidities and mortality in preterm neonates with histologic chorioamnionitis.
• Antenatal steroid administration is a beneficial intervention in the presence of histologic chorioamnionitis, without elevating sepsis risk.